搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Nature
2 天
How CRISPR patent issues block Indian farmers from accessing biotech benefits
Scientists in Asia and Africa are racing to discover hardier crop varieties using gene editing tools. But patent restrictions ...
New Atlas
2 天
Remote-controlled gene therapy uses ultrasound to kill cancer
A new kind of cancer gene therapy can be remotely activated at a specific part of the body. The team developed a version of ...
FiercePharma
11 小时
Vertex, Saudi Arabia ink memorandum of understanding to boost local gene therapy manufacturing
Two Saudi Arabian agencies signed on with Vertex Pharmaceuticals to help boost the countr | The Vertex agreement is part of ...
STAT
2 天
Biotech companies detail emerging efforts to ease ‘conditioning’ before genetic treatments
New genetic medicines for sickle cell disease were hailed as a milestone. Now researchers are working on ways to widen access ...
AZoLifeSciences on MSN
6 天
Cancer Therapy Molecule Boosts CRISPR Efficiency, but at a Cost
The therapy molecule AZD7648 can promote precise DNA repair during CRISPR gene editing, but creates massive genetic changes ...
BioSpace
6 天
Bluebird, Vertex/CRISPR’s SCD Gene Therapies Get New CMS Payment Model
The payment scheme will tie gene therapy payments to improvements in health outcomes—and could potentially boost the uptake ...
BioPharma Dive
14 小时
Chroma, Nvelop merge to marry genetic medicine ‘cargo’ to delivery
The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...
Medindia
10 天
CRISPR Gene Editing for Sickle Cell Disease
CRISPR gene therapy trial for sickle cell disease begins, offering hope for a potential cure by targeting the genetic root of ...
2 天
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual ...
Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈